PhD Nace Zidar

PhD Nace Zidar
no.: 28905 source: ARIS

researcher – active in research organisation
Foreign language skills
Research activity

Code Science Field Subfield
1.09.00  Natural sciences and mathematics  Pharmacy   

Code Science Field
B740  Biomedical sciences  Pharmacological sciences, pharmacognosy, pharmacy, toxicology 
B230  Biomedical sciences  Microbiology, bacteriology, virology, mycology 
medicinal chemistry, drug design, drug synthesis, antibacterial compounds, anticancer compounds, topoisomerases, voltage-gated ion channels
Data for the last 5 years (citations for the last 10 years) on December 10, 2023; A3 for period 2017-2021 (update for tender in 2022: YES)
Data for ARIS tenders ( 14.06.2023 – Target research programmes, archive )
Database Linked records Citations Pure citations Average pure citations
WoS 66  1,401  1,086  16.45 
Scopus 66  1,516  1,191  18.05 
Mentoring junior researchers
source: ARIS
no. Name and surname Type Period Code
1 Martina Piga  Bologna doctoral studies    55894 
source: ARIS
Level of education Professional title Study subject Faculty Year
Bachelor's degree  B. Sc.     SI 2006 
Doctor's degree  Ph. D.   Pharmacy  SI University of Ljubljana, Faculty of Pharmacy 2011 
Doctoral dissertations and other final papers Show
Obtaining results now
source: COBISS
source: ARIS
Type of employment Research org. Research group Date of employment Position Title
Full time employment (120%, RD:100%)  University of Ljubljana, Faculty of Pharmacy  Chair for Pharmaceutical Chemistry  2/1/2007  Assistant  Assistant professor 
Research projects Legend
source: ARIS
ARIS research and infrastructure programmes Legend
source: ARIS
International projects
Nace Zidar graduated from the Faculty of Pharmacy at the University of Ljubljana in 2006 under the supervision of Prof. Dr. Marko Anderluh. After graduation, he obtained a position as a young researcher in the Department of Pharmaceutical Chemistry at the Faculty of Pharmacy. In 2011, he defended his PhD thesis entitled "Design and synthesis of heterocyclic inhibitors of MurC-E ligases" under the supervision of Prof. Dr. Danijel Kikelj, for which he received the 2011 Krka Prize. From 2007-2011 he worked on the EU project INTAFAR, where he was involved in the design and synthesis of new inhibitors of peptidoglycan biosynthesis. In 2011-2015 he worked on the EU project MAREX, which aimed to discover new bioactive compounds from marine sources. In 2013-2015, he led a postdoctoral project funded by the Slovenian Research Agency entitled "Design, synthesis and evaluation of voltage-gated sodium channel modulators". He worked on the EU Marie Skłodowska-Curie ETN INTEGRATE and IMI project ENABLE (European Gramme-negative Antibacterial Engine), where he was involved in the discovery of compounds with activity against resistant Gram-negative bacteria. He is the leader of the research project funded by the Slovenian Research Agency for the discovery of inhibitors of the bacterial enzyme DNA gyrase. In 2017, he completed his postdoctoral training at the Department of Chemistry, University of Milan. His research interests include rational design, synthesis and evaluation of new bioactive compounds, especially with antibacterial (bacterial topoisomerase, Mur ligases) and anticancer activity (human topoisomerases, voltage-gated ion channels). He is also interested in physicochemical evaluation of compounds and development of instrumental analytical methods important in pharmacy.
Views history